Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine sulfate eye drops (different concentrations) to slow myopia progression in children: randomized double-blind placebo-controlled phase III trial
CTR20231097Phase 3Active
- Sponsor
- Hangzhou Health Biotech
- Start
- May 2023
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atropine in myopia, sponsored by Hangzhou Health Biotech. Started May 2023; status: active.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on CTR20231097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231097.